July 29th 2025
Paris, July 29, 2025 – 6:00 pm CEST
CARMAT (FR0010907956, ALCAR), designer and developer of the world’s most advanced total artificial heart, aiming to provide a therapeutic alternative for people suffering from advanced biventricular heart failure (the “Company” or “CARMAT”), today provides an update on its situation and the ongoing receivership procedure and announces the suspension of trading in CARMAT shares, starting July 30, 2025, before stock market opening, ahead of the deadline of July 31, 2025 for submitting takeover or investment offers, set by the judiciary administrator.
Update on Company’s operations and cash runway
Given its limited financial resources, the Company has, since the beginning of the observation period on July 1, 2025, reduced its activities to focus on the one hand on supporting patients already implanted with its Aeson® artificial heart, and on the other hand, on regulatory and operational activities deemed key in view of resuming operations in the best possible way once its financial sustainability has been secured, i.e. obtaining CE marking under “MDR” regulation, maintaining infrastructures, particularly for manufacturing, pursuing Aeson® enhancements with a view to releasing a product version suitable for long-term patient support by the end of 2025, and preparing for the publication of the EFICAS clinical study results at the end of the year.
In this context of uncertainty, all new Aeson® implants, whether for commercial purposes or as part of clinical trials are suspended during the months of July and August 2025.
As a result of the above, the Company’s cash runway has been extended until the end of August 2025.
Update on the ongoing receivership procedure
On July 3, 2025, CARMAT had announced the initiation of a call for public tenders (buyers or investors) as part of the receivership procedure opened on July 1, 2025 by the Versailles Economic Affairs Court (the “Court”). The deadline for submitting offers (the “Offers”) is July 31, 2025.
The next Court hearing is scheduled on August 19, 2025. Should Offers be received by the judiciary administrator, they would be examined by the Court at this hearing.
Suspension of CARMAT shares trading (ISIN code: FR0010907956, Ticker: ALCAR)
Ahead of the deadline for submitting Offers, i.e., July 31, 2025, CARMAT has asked Euronext to suspend the trading of its shares starting on Wednesday, July 30, 2025, before the stock market opens.
The Company anticipates this suspension to be lifted once the outcome of the Offers’ submission process is known and communicated to the market.
Press releases will be issued regularly as the Company’s situation evolves and the proceedings progress.